Pregabalin Capsule 75mg (Pregabalin)

Adult dose

As Pregabalin, this medication should be taken orally, divided into two doses daily, not dependent on food. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose 150 mg daily, can be increased to 300 mg within 3 to 7 days, and if necessary, can be increased to a maximum of 600 mg daily at intervals of 7 days. - Central neuropathic pain: Starting dose 150 mg daily, 1.

Child dose

There is insufficient safety and efficacy data for pediatric patients under 12 years of age and adolescents aged 12–17 years, therefore administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so patients should be monitored carefully for symptoms of depression, mood changes, or unusual behavior during treatment. If you have an allergy to any of the ingredients, do not take this medication. Diabetic patients should be cautious as dose adjustment of blood sugar control medications may be needed due to weight gain. If symptoms of angioedema appear, such as swelling of the face or around the mouth, discontinue use immediately. Elderly patients may experience dizziness or drowsiness, which increases the risk of accidents, so they should be particularly cautious at the beginning of treatment. Transient visual disturbances or changes in vision may occur, which may improve upon discontinuation of the medication. There is insufficient data available to change the dosage of this medication alone when used in conjunction with other antiepileptic drugs, so caution is necessary. Discontinuation of this medication should not be abrupt, as withdrawal symptoms such as insomnia, headache, and anxiety may arise; therefore, tapering should be done according to a physician's directive. Patients with a history of substance abuse may be at higher risk for abuse of this medication and should be monitored closely. Patients with impaired renal function may require dose adjustment. Patients with severe cardiovascular disease should use caution when administering this medication. When taken with opioid analgesics, there may be an increased risk of central nervous system depression. Patients with respiratory or neurological conditions, renal impairment, or the elderly may be at risk of respiratory depression and may require dose adjustments. Pregnant women should avoid this medication due to the risk of fetal malformation in early pregnancy, and women of childbearing potential should use effective contraception. This medication can cause dizziness and drowsiness, so caution should be taken when driving or operating hazardous machinery. If severe skin rash or allergic reactions occur, discontinue the medication immediately and consult healthcare providers. This medication does not have significant pharmacokinetic interactions with other drugs; however, effects may be enhanced if taken with alcohol or central nervous system depressants. Breastfeeding mothers should consult with healthcare professionals before using this medication due to the potential transfer into breast milk affecting the infant. In case of overdose, symptoms may include drowsiness, confusion, and seizures, necessitating immediate medical treatment. Keep this medication out of reach of children and do not transfer it to another container.

Serious side effects

Hives, severe swelling (angioedema), tightness in chest, difficulty breathing, cold sweats, pallor, severe rash accompanied by fever, blisters, skin peeling, pain in mouth/eye mucous membranes, shortness of breath or difficult breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis.

Mild side effects

Dizziness, drowsiness, confusion, disorientation, irritability, depression, euphoria, decreased libido, insomnia, depersonalization, hypersensitivity, restlessness, anxiety, mood swings, emotional lows, emotional highs, difficulty finding appropriate terminology, hallucinations, abnormal dreams, increased libido, panic attacks, impulsivity, numbness, ataxia, abnormal motor coordination, balance disturbances, memory loss, attention deficit, memory impairment, trembling, speech disorders, sensory disturbances, sensory loss.

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. It is best to maintain a storage temperature between 15 to 30 degrees Celsius. This will help preserve the efficacy and safety of the medication.

Appearance

A hard capsule with a reddish-brown upper part and a white lower part containing white powder.

Package unit

30 capsules/bottle, 100 capsules/bottle